Clinical Trials Directory

Trials / Unknown

UnknownNCT03014882

Sperm DNA Damage in β-thalassemia Major: Is There a Role for Antioxidants?

Status
Unknown
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Ain Shams University · Academic / Other
Sex
Male
Age
16 Years
Healthy volunteers
Accepted

Summary

Accumulation of iron in patients with beta thalassemia major causes free radical formation which leads to damage of biological membranes. Sperm DNA damage may result from these generated antioxidants. We aimed at investigating the current DNA damage in the sperms of adult patients with beta thalassemia major and the effect generated by giving antioxidant treatment for 6 months.

Conditions

Interventions

TypeNameDescription
DRUGL-Carnitine and N-acetyl cysteine

Timeline

Start date
2015-02-01
Primary completion
2017-12-01
Completion
2017-12-01
First posted
2017-01-09
Last updated
2017-01-09

Locations

3 sites across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03014882. Inclusion in this directory is not an endorsement.

Sperm DNA Damage in β-thalassemia Major: Is There a Role for Antioxidants? (NCT03014882) · Clinical Trials Directory